Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease
- PMID: 23392440
- DOI: 10.1164/rccm.201209-1665OC
Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease
"V体育2025版" Abstract
Rationale: Comorbidities contribute to disease severity and mortality in patients with chronic obstructive pulmonary disease (COPD). Comorbidities have been studied individually and were mostly based on self-reports. The coexistence of objectively identified comorbidities and the role of low-grade systemic inflammation in the pathophysiology of COPD remain to be elucidated VSports手机版. .
Objectives: To cluster 13 clinically important objectively identified comorbidities, and to characterize the comorbidity clusters in terms of clinical outcomes and systemic inflammation V体育安卓版. .
Methods: A total of 213 patients with COPD (FEV1, 51 ± 17% predicted; men, 59%; age, 64 ± 7 yr) were included prospectively. Comorbidities were based on well-known cut-offs identified in the peer-reviewed English literature. Systemic inflammatory biomarkers were determined in all patients V体育ios版. Self-organizing maps were used to generate comorbidity clusters. .
Measurements and main results: A total of 97. 7% of all patients had one or more comorbidities and 53. 5% had four or more comorbidities. Five comorbidity clusters were identified: (1) less comorbidity, (2) cardiovascular, (3) cachectic, (4) metabolic, and (5) psychological VSports最新版本. Comorbidity clusters differed in health status but were comparable with respect to disease severity. An increased inflammatory state was observed only for tumor necrosis factor (TNF) receptors in the metabolic cluster (geometric mean [lower and upper limit]; TNF-R1, 2,377 [1,850, 3,055] pg/ml, confidence, 98. 5%; TNF-R2, 4,080 [3,115, 5,344] pg/ml, confidence, 98. 8%) and only for IL-6 in the cardiovascular cluster (IL-6, 3. 4 [1. 8, 6. 6] pg/ml; confidence, 99. 8%). .
Conclusions: Multimorbidity is common in patients with COPD, and different comorbidity clusters can be identified. Low-grade systemic inflammation is mostly comparable among comorbidity clusters. Increasing knowledge on the interactions between comorbidities increases the understanding of their development and contributes to strategies for prevention or improved treatment V体育平台登录. .
"V体育安卓版" Comment in
-
Chronic obstructive pulmonary disease is just one component of the complex multimorbidities in patients with COPD.Am J Respir Crit Care Med. 2013 Apr 1;187(7):668-71. doi: 10.1164/rccm.201302-0230ed. Am J Respir Crit Care Med. 2013. PMID: 23540872 No abstract available.
-
Objectively identified comorbidities in COPD: impact on pulmonary rehabilitation outcomes.Eur Respir J. 2015 Aug;46(2):545-8. doi: 10.1183/09031936.00026215. Epub 2015 Jun 25. Eur Respir J. 2015. PMID: 26113670 No abstract available.
"VSports手机版" Publication types
- VSports注册入口 - Actions
MeSH terms (V体育2025版)
- "VSports注册入口" Actions
- Actions (V体育2025版)
- VSports最新版本 - Actions
- Actions (V体育安卓版)
- Actions (V体育平台登录)
- Actions (V体育官网)
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical